🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to provide dose-ranging data for 4 dose regimens o...
Status
Completed
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2019-07-31
Trial ID
NCT04015518
Treatments Being Tested
The primary objective of this trial is to investigate the safety and effica...
Status
Completed
Location
Dr. Irina Turchin PC Inc.
Start Date
2017-05-30
Trial ID
NCT03135548
Treatments Being Tested
This is a study in adolescents and adults with Generalized Pustular Psorias...
Status
Completed
Location
Oakland Hills Dermatology
Start Date
2020-06-04
Trial ID
NCT04399837
Treatments Being Tested
The primary objective of this trial is to investigate the relative bioavail...
Status
Completed
Location
SGS Life Science Services - Clinical Research
Start Date
2017-04-24
Trial ID
NCT03100903
Treatments Being Tested
This study is open to people with hidradenitis suppurativa (HS) who have co...
Status
Terminated
Location
First OC Dermatology
Start Date
2024-05-08
Trial ID
NCT06241573
Treatments Being Tested
The primary objective of this trial is to investigate the relative bioavail...
Status
Completed
Location
SGS Life Science Services - Clinical Research
Start Date
2018-08-16
Trial ID
NCT03617835
This trial has two sequentially enrolling parts with different objectives. ...
Status
Completed
Location
Medical Research Center of Connecticut, LLC
Start Date
2018-03-27
Trial ID
NCT03482635
Treatments Being Tested
This study is open to adults with moderate to severe hidradenitis suppurati...
Status
Completed
Location
First OC Dermatology
Start Date
2023-04-17
Trial ID
NCT05819398
The primary objective of this trial is to investigate the safety and tolera...
Status
Completed
Location
Inje University Busan Paik Hospital
Start Date
2017-05-16
Trial ID
NCT03123094
Treatments Being Tested